Flexible non-contact wound treatment device with a single joint

Abstract
A non-contact wound treatment device suitable for releasable attachment to a patient's skin surface over a selected wound area in a non-contact position relative to the selected wound area, the wound treatment device comprising an attachment portion suitable for releasable attachment with the patient's skin surface, having an inner perimeter for defining the selected wound area, a wound treatment portion with a wound cover and a support member supporting the wound cover, and a transition portion with a joint connecting the wound treatment portion to the attachment portion.
Description




This application contains material related to the U.S. Patent application filed on even date herewith that is entitled “FLEXIBLE NON-CONTACT WOUND TREATMENT DEVICE” and to the following pending U.S. Patent applications all assigned commonly with this application:




Ser. No. 07/900,656, filed Jun. 19, 1992, for “THERMAL BODY TREATMENT APPARATUS AND METHOD”;




Ser. No. 08/356,325, filed Feb. 21, 1995, for “WOUND COVERING”;




Ser. No. 08/785,794, filed Jan. 21, 1997, for “NORMOTHERMIC HEATER WOUND COVERING”;




Ser. No. 08/86,713, filed Jan. 21, 1997, for “NORMOTHERMIC TISSUE HEATING WOUND COVERING”;




Ser. No. 08/786,714, filed Jan. 21, 1997, for “NEAR HYPOTHERMIC HEATER WOUND COVERING”.




Technical Field




This invention relates to a wound treatment device and, in particular, to a wound treatment device having a substantial portion of a wound cover that is in non-contact with a wound and capable of delivering heat to the wound. More particularly, the wound treatment device includes such a wound treatment device with a single joint that maximizes the ability of the wound treatment device to adapt to the contours and movements of a human body.




BACKGROUND OF THE INVENTION




A novel mode of wound treatment is disclosed in detail in published PCT Applications WO 94/00090 and WO 96/15745, both owned in common with this application. This new treatment employs a non-contact wound treatment device that covers a wound, forming a treatment volume about and over the wound. An embodiment of such a wound treatment device may be characterized in having a plurality of parts, three of which are useful for the purpose of description. These. three parts are an attachment portion, a wound treatment portion, and a transition portion. Each portion serves a respective function.




The attachment portion connects and retains the wound treatment device on the skin of a person. The wound treatment portion typically includes a standoff that rises above the person's skin surface, and a wound cover that spans an open portion of the standoff. Together, the standoff and wound cover define a wound treatment volume and a wound treatment area onto which the wound treatment volume is projected.




The transition portion connects the attachment portion to the wound treatment portion. An important function of the transition portion is to adapt the wound treatment device to the contour of the portion of a person's body where the device is mounted and to movements of the person's body that deform the wound treatment device in situ. In this regard, an important function of the transition portion is the accommodation of patient motion by the compliance of the transition portion.




Achievement of this important function of the transition portion is challenged by the need to maintain the orientation of the wound cover in the wound treatment portion —both in aspect and location —with respect to the wound being treated. The orientation of the wound cover is difficult to maintain when the wound treatment device is mounted on a highly curved part of a body. While the wound treatment devices disclosed in the referenced PCT applications exhibit excellent adaptability in a surface that is parallel to the surface of the body portion where the wound treatment device is mounted, there is impairment of adaptability and disturbance of the orientation of the wound cover due to limited flexibility in the direction of a Z axis that is perpendicular to the surfaces. If the transition portion is substantially perpendicular to the attachment portion, it may buckle in response to body motion or contour and collapse the standoff in the wound treatment portion. The collapse of the standoff of course alters the orientation of the wound cover with respect to the wound, possibly reducing the effectiveness of the wound treatment device.




Z axis conformability is especially important for a wound treatment device used on a portion of a person's lower leg. The lower leg has a very tight radius of curvature. Therefore, when a three-dimensional wound treatment device is curved around a lower leg, substantial stress results that may result in deformation of the shape of the wound treatment device, in some cases even causing the wound cover to contact the wound.




SUMMARY OF THE INVENTION




The overall flexibility of a wound treatment device is enhanced by an invention based upon the inventors'critical realization that provision of a joint in the transition portion that connects the wound treatment portion to the attachment portion accommodates patient motion and contour by providing articulation between these portions that permits flexion of the wound treatment device in all dimensions of the volume that the wound treatment device occupies.




In this invention, the joint connects the wound treatment portion to the attachment portion, extending between the standoff and the attachment portion. The joint attaches to the attachment portion under the standoff between inner and outer perimeters of the attachment portion.




Preferably, the inner perimeter of the attachment portion is limited to being contained within the outer perimeter of the standoff. This permits reduction of the size of the attachment portion, minimizing the total “foot print” of the wound treatment device. A smaller footprint is generally considered to be advantageous particularly when attaching the wound treatment device to a highly curved part of a person's body, such as the surface of a lower leg.




The joint, its connection of the standoff with the attach mnent portion, and its attachment to the attachment portion between inner and outer perimeters of the attachment portion provides a hinge-like operation that maximizes the adaptability of the wound treatment device and maintains the orientation of the wound cover over greater ranges of body curvature and movement than previously obtainable.




It is, accordingly, an objective of this invention to provide a flexible, non-contact wound treatment device that adapts to body curvature and motion.




Another objective is the provision of a non-contact wound treatment device having a wound treatment portion and an attachment portion, with a joint between the wound treatment and attachment portions.




It is a related objective in this latter regard to provide a joint between the wound treatment and attachment portions in the form of an accordion- or bellows-like member operating between the bottom of the standoff in the wound treatment portion and the attachment portion.




It is a further related objective to provide a joint between the wound treatment and attachment portions in the form of a seam joining these portions and permitting articulation therebetween.




A significant advantage of the invention is the potential reduction in size of the attachment portion, providing a smaller footprint of the wound treatment device.











BRIEF DESCRIPTION OF THE DRAWINGS




The various figures of the drawing depict illustrative and exemplary forms of the wound treatment device. Throughout the several views, identical reference characters represent similar or equivalent structures wherein:





FIG. 1

is a perspective view of one embodiment of the wound treatment device;





FIG. 2

is a schematic view of projected areas;





FIG. 3

is a schematic view of projected areas;





FIG. 4

is a perspective view of a detachable heater in combination with the one embodiment of a wound treatment device;





FIG. 5

is an exploded view of the one embodiment of a wound treatment device;





FIG. 6

is an exploded view of another embodiment of a wound treatment device;





FIG. 7

is a perspective view of a heater system;





FIG. 8

is an electrical schematic of a pressure sensitive switch for a heater system;





FIG. 9A

is an exploded view of a pressure sensitive switch incorporated into a wound treatment device;





FIG. 9B

is a view of a portion of the pressure sensitive switch;





FIG. 10

is a perspective view of a passive heater embodiment of the wound treatment device;





FIG. 11A

is a schematic drawing depicting an alternate geometry for the transition portion;





FIG. 11B

is a schematic drawing depicting an alternate geometry for the transition portion;





FIG. 11C

is a schematic drawing depicting an alternate geometry for the transition portion;





FIG. 11D

is a schematic drawing depicting an alternate geometry for the transition portion;





FIG. 12A

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 12B

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 13A

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 13B

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 14A

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 14B

is a schematic drawing depicting functional relationships between several elements of the invention;





FIG. 15

is a perspective view of an embodiment of a flexible non-contact wound treatment device;





FIG. 16

is a perspective view of a detachable heater in combination with the embodiment of

FIG. 15

;





FIG. 17

is an exploded view of the embodiment of

FIG. 15

;





FIG. 18A

is a cross-sectional perspective view of the embodiment of the

FIG. 15

referred to A—A in

FIG. 15

;





FIG. 18B

is a cross-sectional perspective view of the embodiment of

FIG. 15

showing the operation of a membrane in adapting the wound treatment device to body motion referred to A—A in

FIG. 15

;





FIG. 18C

is a magnified partial cross-sectional view of the embodiment of

FIG. 15

showing further operation of the membrane in accommodating body motion;





FIG. 19A

is a side elevational view of the cross-sectional view of

FIG. 18B

when attached to a human patient;





FIG. 19B

is a side elevational view representing the cross-sectional view of

FIG. 18C

;





FIG. 20

is a perspective view of our invention, embodied as a flexible non-contact wound treatment device with a single flexion joint;





FIG. 21

is a cross-sectional perspective view of a first preferred embodiment referred to A—A in

FIG. 20

;





FIG. 22

is an exploded view of the cross-sectional illustration of the first embodiment;





FIG. 23

is a cross-sectional side view of the first embodiment, when attached to a human patient;





FIG. 24

is a cross-sectional perspective view of a second embodiment referred to in A—A in

FIG. 20

;





FIG. 25

is an exploded cross-sectional view of the second embodiment; and





FIGS. 26A

, B, and C are cross-sectional side views of the second embodiment when attached to a human patient;





FIG. 27

is perspective view of a third preferred embodiment;





FIG. 28

is a cross-sectional perspective view of a third preferred embodiment referenced to B—B in

FIG. 27

; and





FIG. 29

is a cross-sectional side view of the third embodiment.











DETAILED DESCRIPTION




For an understanding of the invention that is disclosed and claimed in this application, reference is made to

FIGS. 1-10

in which embodiments and elements of a wound treatment device are illustrated. With reference especially to

FIG. 1

, a wound treatment device


10


has a planar upper surface displaced above the skin surface of the patient or person having a wound that is being treated by application and operation of the device


10


. The wound treatment device


10


further includes an attachment surface generally held in a plane or surface that is coincident with the plane or surface of the person's skin. Together these two surfaces define an enclosed, non-contact volume over a wound treatment site.




The wound treatment device


10


that is illustrated in

FIG. 1

may be considered in a general way for the purpose of description. In this regard, the description of a wound treatment device is aided by considering three separate parts of the wound treatment device


10


. These parts are an attachment portion


12


, a wound treatment portion


14


, and a transition portion


16


. Each portion is designed to serve a separate f unction.




The attachment portion


12


is used to connect the wound treatment device


10


to the skin of a patient. The wound treatment portion


14


of the wound treatment device


10


defines a vertical extent or dimension of the wound treatment device


10


, and thus defines the location of the attachment surface. The transition portion


16


connects the attachment portion


12


to the wound treatment portion


14


. The transition portion


16


is provided to improve the comfort and utility of the wound treatment device


10


when the patient moves and stretches the device.





FIG. 1

is a perspective view of a wound treatment device


10


applied to a patient's skin surface


18


. A coordinate system


11


is depicted on the patient's skin surface


18


and it defines X, Y and Z directions. An attachment portion


12


is formed as an planar rim or flange. This attachment portion


12


is attached to the patient's skin


18


with an adhesive and it lies in a first XY plane. In this embodiment of wound treatment device


10


, a transition portion


16


is integrally formed with attachment portion


12


. Transition portion


16


rises from the skin surface in the Z direction to connect to a wound treatment portion


14


. In this embodiment, wound treatment portion


14


has a transparent planar wound cover


20


which allows one to see a wound treatment area


28


. Wound cover


20


is supported above the first XY plane by a foam ring standoff


15


. Wound cover


20


lies in a second XY plane that is vertically displaced along the Z-axis by foam ring standoff


15


from the first XY plane. Wound cover


20


and foam ring standoff


15


together form wound treatment portion


14


. The region over wound treatment area


28


is called a wound treatment volume


24


.




In this figure, wound treatment device


10


has been applied to a patient's skin and is in a relaxed state. In this unstressed state one can see an outer periphery


22


of attachment portion


12


. An inner periphery


23


is shown by a crease in the structure where it connects to transition portion


16


.




FIG.


2


and

FIG. 3

should be considered together where they show the influence of patient motion on wound treatment device


10


. Both FIG.


2


and

FIG. 3

are top views of wound treatment device


10


of

FIG. 1

with the various portions of wound treatment device


10


projected onto the first XY plane.




In

FIG. 2

, the wound covering is shown in a relaxed and un-stretched state having a nominal total projected area


27


. Projected wound treatment area


28


is shown at the center of the wound treatment device


10


. The outline of foam ring standoff


15


may be seen as the crosshatch area bounded by an exterior perimeter


25


of foam ring standoff


15


, and an interior perimeter


26


of foam ring standoff


15


. A transition portion projected area


17


is bounded by inner periphery


23


of attachment portion


12


, and interior perimeter


26


of foam ring standoff


15


. An attachment portion projected area


40


is shown as that cross hatched area bounded by outer periphery


22


and inner periphery


23


of attachment portion


12


.





FIG. 3

shows wound treatment device


10


stretched along the X-axis by patient motion. In comparison to

FIG. 2

, the overall or total projected area


27


of wound treatment device


10


has increased. Attachment portion projected area


40


has increased slightly as attachment portion


12


moves with the underlying skin. Projected wound enclosure area


28


is essentially unchanged in area since in this embodiment foam ring standoff


15


is free move against the skin. The largest percentage area change occurs in transition portion projected area


17


. As wound treatment device


10


deforms in response to patient motion, transition portion


16


is compliant and pays out material permitting the majority of the increase in total projected area


27


to be accommodated primarily by transition portion projected area


17


.





FIG. 4

shows a detachable heater


32


positioned for insertion into a pocket formed by pocket cover


21


. Pocket cover


21


is bonded to wound cover


20


and is sized to retain heater


32


. Foam ring standoff


15


and wound cover


20


serve to stabilize the shape of wound treatment device


10


while transition portion


16


accommodates patient motion. Consequently, heater


32


is reliably and comfortably positioned above the wound surface. In general, it is desirable to use a planar heater as heater


32


which has a prescribed heat output per unit area. This form of heater results in a more uniform flux of radiant energy applied to the wound. The amount of heat supplied to the wound area is largely independent of the height of heater


32


above the wound surface within the range of finctional heights of this device. In some cases, non-uniform wound area heating might be desirable and therefore the watt density of the heater may be non-uniform across its surface.





FIG. 5

is an exploded view of the first embodiment of wound treatment device


10


. Attachment portion


12


and transition portion membrane


36


are formed as a unitary composite shell


38


. Composite shell


38


may be vacuum formed from closed cell polyolefin foams such as Volara-6AS, which is a polyethylene material as sold by Illbruck Inc., of Minneapolis, Minn. It should be apparent that many other materials may be substituted within the scope of the invention. Foam ring standoff


15


may be die cut from foam sheeting of a reticulated polyurethane foam. The absorbency of the foam as well as its mechanical properties can be tailored to the particular wound treatment application. For example, the foam standoff may be impregnated with a medicament such as an antibiotic, antifungal, or antimicrobial material. It may also be desirable to supply a deodorant material or nitric oxide releasing material from the foam standoff. Wound cover


20


and wound pocket


21


may be made from a thin film of polyethylene. In general, the composite shell should be sufficiently self supporting so that when wound treatment device


10


is removed from its release liner, wound treatment portion


14


is held up or supported by the shaped flexion joint of transition portion membrane


36


, and some effort is required to evert composite shell


38


and turn it inside out This behavior defines the self supporting feature which causes foam ring standoff


15


to lie gently against the skin even when wound treatment device


10


is upside down. For larger wound coverings it may be desirable to apply a tacky adhesive to the patient contact surface of the standoff.





FIG. 6

is an exploded view of another embodiment of wound treatment device


10


. Attachment portion


12


and transition portion membrane


36


are formed as a unitary composite shell


38


. In this embodiment, the wound treatment volume is defined by a serrated cup standoff


34


. Standoff


34


may be made from a more rigid polymeric material, such as polyethylene, or the like. The serrations typified by a plurality of serrations


44


permit serrated cup standoff


34


to flex and accommodate patient motion. This embodiment shows a release liner


42


coupled to attachment portion


12


of composite shell


38


with an adhesive


46


. In this embodiment, pocket cover


21


is bonded to composite shell


38


.





FIG. 7

depicts a portable power supply


48


to provide for the ambulatory use of the heated versions of the wound treatment device. A collection of battery cells may be wired together to form power supply


48


which may be conveniently attached to a belt


49


. A suitable cable


50


may be used to conduct power to heater


32


. In many instances, it may be desirable to cut off power to heater


32


if wound treatment device


10


is collapsed against the wound so as to prevent overheating of the wound surface.





FIG. 8

shows a schematic representation of a touch switch


52


which may be incorporated directly into detachable heater


32


. Heater


32


includes a continuous resistive heating coil


51


. A conductive membrane makes up touch switch


52


and is arranged near heating coil


51


so that it may “short out” segments or portions of coil


51


it touches. In use, all power to heating coil


51


is completely turned off by pressure applied to an entire touch sensor


53


.





FIG. 9A

shows an exploded version of heater


32


incorporating a touch switch


52


of the type described schematically in

FIG. 8. A

switch cover


45


has a conductive membrane which is located over the conductive pattern of heating coil


51


. It is held in position with an adhesive band


54


.

FIG. 9B

shows the underside of switch cover


45


showing a plurality of discrete insulation bumps typified by a bump


47


which serve to space and support touch switch


52


above heating coil pattern


51


. Pressure supplied to switch cover


45


inactivates heater coil


51


.





FIG. 10

shows an accessory device


55


or cover. This may take the form of a passive heater (or insulator) with a reflective surface facing the wound. Accessory device


55


may also take the form of a mapping grid where a grid work of lines is positioned on a transparent card to permit tracking of the wound healing process.




FIG.


11


A through

FIG. 11D

should be considered together. These drawings facilitate a description of the connection of the various structures of the invention and represent several alternative connection geometries. In general, to accommodate patient motion, the transition portion pays out stored material to increase the projected area of the transition portion. Each of these drawings represents a mechanical schematic cross section of a wound treatment device


10


in the XZ plane. In each FIGURE, the wound covering is in the relaxed state.





FIG. 11A

shows a schematic view of a ring standoff


15


extending from a first plane


56


to a second plane


58


. Transition portion


16


has a transition portion membrane


60


which is coupled to attachment portion


12


by a first flexible connection


62


formed at the intersection of attachment portion


12


and transition portion


16


. Transition portion membrane


60


is connected to treatment portion


14


at a second flexible connection


64


which is formed at the intersection of transition portion


16


and wound treatment portion


14


. Wound treatment portion


14


is generally a cylindrical cup-shaped structure defining a wound treatment area on the patient skin surface. A minimum interconnection distance


66


is depicted as a dashed line extending from first flexible connection


62


to second flexible connection


64


. The length of minimum interconnection distance


66


can be used to characterize the “length” of transition portion membrane


60


. For many embodiments of the invention, the length of transition portion


16


between first flexible connection


62


and second flexible connection


64


is greater than the length of the straight line drawn between these points. This relationship is true for many embodiments of the wound treatment device when they are in the relaxed or unstressed position. It should be noted that the vertical distance between first plane


56


and second plane


58


represents a minimum value for minimum interconnection distance


66


. In the XY plane, first flexible connection


62


forms a first perimeter


61


and a second perimeter


63


. In the embodiment depicted in

FIG. 11A

, first perimeter


61


is larger than second perimeter


63


.





FIG. 11B

is a mechanical schematic diagram which represents a cross section of another embodiment of the wound treatment device


10


with an alternate connection geometry. In this drawing, wound cover


20


extends radially beyond wound treatment volume


24


so that a second perimeter


68


is greater than a first perimeter


71


. This generates a reflex transition portion


74


construction which may be adopted to increase the “length” and amount of material in the reflex transition portion


74


.





FIG. 11C

shows a construction where a first perimeter


76


and a second perimeter


78


have approximately the same value and are both concentric with an axis


90


. This construction can produce an undulated transition portion


77


. Once again, the length of undulated transition portion


77


exceeds the length of a line


65


between first perimeter


76


and second perimeter


78


.





FIG. 11D

shows a hemispheric shell


70


as wound treatment portion


14


. In this embodiment a second perimeter


80


is a single line of attachment that is generally concentric with axis


90


. In this embodiment, a first perimeter


81


has a length which greatly exceeds the length of second perimeter


80


. This construction forms a hemispheric transition portion


79


which has a length which exceeds the linear distance between second perimeter


80


and first perimeter


81


along a line


85


.




Although the various geometries vary in detail, it is preferable to form transition portion


16


from a resilient material which is generally self-supporting, yet sufficiently flexible so that it acts as a compliant hinge mechanism. This flexibility substantially limits the transfer of shearing force from wound treatment portion


14


to attachment portion


12


of the wound treatment device


10


, and visa versa. With the geometries set forth in FIG.


11


A through

FIG. 11D

, transition portion


16


of wound treatment device


10


forms a shaped flexion joint or formed expansion joint which stores “material” in a pleat, convolution, bellows, or the like. This type of structure provides a means for expanding the size of transition portion


16


resulting in minimizing the transfer of forces from attachment portion


12


to wound treatment portion


14


.




FIG.


12


A through

FIG. 14B

should be considered together. In these embodiments of the invention, the standoff structure reduces in height resulting in increased transition portion projected area


17


during the stretching of the wound treatment device.





FIG. 12A

shows a part of a wound treatment device having foam ring standoff


15


in the unstressed or relaxed state. In this instance, transition portion projected area


17


is proportional to a dimension


88


. In

FIG. 12B

, the wound treatment device has been stretched and the height of foam ring standoff


15


is reduced in the Z direction which has increased transition portion projected area


17


as represented by dimension


91


.





FIG. 13A

shows a part of a wound treatment device having serrated cup standoff


34


in the unstressed or relaxed state. In this instance, transition portion projected area


17


is proportional to a dimension


98


. In

FIG. 13B

, the wound treatment device has been stretched, and the height of serrated cup standoff


34


is reduced in the Z direction. The serrated wall sections splay out to permit the height reduction which increases transition portion projected area


17


as represented by a dimension


99


.





FIG. 14A

shows a part of a wound treatment device having foam ring standoff


15


in the unstressed or relaxed state. However, in this construction attachment portion


12


and a transition portion membrane


96


lie entirely in first plane


56


. In this instance, transition portion projected area


17


is proportional to a dimension


94


. In

FIG. 14B

, the wound treatment device has been stretched and the height of the foam ring standoff


15


is reduced in the Z direction. This height reduction increases transition portion projected area


17


represented by a dimension


92


.




A flexible, non-contact wound treatment device is illustrated in

FIGS. 15-19B

where the same reference numerals specify identical parts throughout the drawings.





FIG. 15

is a perspective view of a flexible, non-contact wound treatment device


100


for application to a patient's skin surface. An attachment portion


102


is formed as a collar or flange. This attachment portion


102


is for attachment around a wound through an adhesive layer on the underside of the attachment portion. The embodiment of wound treatment device


100


also embraces a wound treatment portion


104


that includes a wound cover


105


, described below, supported by a support member in the form of a standoff


106


. A transition portion


108


connects the wound treatment portion


104


to the attachment portion


102


and preferably includes a membrane


110


that extends around an outer periphery of the support member


106


and is attached to the attachment portion


102


between inner and outer peripheries thereof.




Referring now to

FIGS. 15 and 17

, in the wound treatment device


100


, the attachment portion


102


is an integrated, unitary assembly preferably having three sections: a foam layer


111


, an adhesive film layer


112


on a bottom surface of the foam layer


111


, and a release liner


113


covering the adhesive film layer


112


. One or more lines of weakness or perforation


114


are provided on the release liner


113


so that its parts may be separated and selectably peeled off of the adhesive film layer


112


, thereby to expose the adhesive film layer


112


a section at a time for application to a person's skin. The foam layer


111


may comprise a naturally open-celled polyurethane foam. The foam layer


111


is preferably approximately


{fraction (1/8″+L )} thick. The adhesive film layer 112 may comprise a high MVTR thin film, pressure sensitive adhesive (PSA) laminate available as a package under the trade name Mediderm from Bertek. The foam layer 111 is heat bonded to the adhesive film layer 112. The material of which the adhesive film layer 112 is comprised is selected for a combination of adhesion level, permeability, and conformability (stretching and flexing with the skin) to allow prolonged skin contact, without complications. The release liner 113 is a white release paper coated with a release agent that is provided on the Mediderm 3701 product. The perforations or slits 114 are made during assembly to aid in the removal of the release liner 113 prior to attachment of a wound treatment device to a person.






When


111


,


112


and


113


are assembled, the attachment portion


102


is a flexible collar shaped part with an inner periphery portion


111




i


on an upper surface


111




s


of the foam layer


111


around an inner perimeter, or edge,


111




e


. The upper surface


111




s


faces, and is therefore disposed under, or beneath, the support member


106


. The attachment portion


102


further includes an outer perimeter, or edge,


111




o.






The wound treatment portion


104


includes the support member


106


, which is preferably a ring of absorbent foam such as a naturally open-celled polyurethane foam that is selected to have favorable characteristics of absorbency, leaking and resevoiring. Such material is available as a product sold under the trade name Aquazone from Foamex. The support member


106


has an upper surface


107


, a lower surface (


109


in FIGS.


18


B-


19


B), an outer perimeter, or edge,


118


and an inner perimeter, or edge,


119


. The thickness of the support member


106


is preferably in a range extending from


{fraction (1/2″+L )} to




{fraction (5/8″+L )}, with the exact dimension being selected to maintain non-contact at wound sites whereby, during use, the foam ring can compress and conform without the wound cover contacting the wound. The wound cover 105 in the preferred embodiment includes a layer 120 preferably of


4 mil.-thick clear, flexible polyurethane film with favorable characteristics selected, but not limited, to include moisture vapor transfer, oxygen permeability, and transmission of infrared radiation. Such material is available as a product sold under the trade name Deerfield 6100S. The layer


120


is attached to the upper surface


107


of the support member


106


by a ring


124


of adhesive comprising a synthetic rubber-base adhesive such the product sold under the trade name HL-2306-X by H. B. Fuller Adhesive. When the layer


120


is attached to the upper surface


107


of the support member


106


, a perimeter portion


121


of the layer


120


extends out beyond the outer perimeter


118


of the support member


106


. The wound cover


105


further includes a stretcher layer


125


attached to the layer


120


so that the layer


120


is sandwiched between the stretcher layer


125


and the upper surface


107


of the support member


106


. The stretcher layer


125


is a 5 mil-thick planar sheet of (preferably) clear, somewhat flexible polyester film having enough stiffness to aid in maintaining planarity of the wound treatment portion


104


. The function of the stretcher layer


125


is to hold the layer


120


taut, much as a “stretcher frame” tautens an artist's canvas. The stretcher layer


125


is attached to the layer


120


by a layer


126


of adhesive comprising a clear flexible polyester carrier film coated on both sides with an aggressive adhesive. The adhesive layer


126


is oriented over the support member


106


. A film carrier allows for the adhesive to be run in a web process and die cut during manufacturing of the stretcher layer


125


. The stretcher layer


125


further includes a pair of slits


128


that receive a detachable heater. With the provision of the slits


128


, a pocket is formed between the stretcher layer


125


and the layer


120


.




The transition portion


108


includes a lower collar


130


that is preferably formed from the same material as the layer


120


. The transition portion


108


also includes the outer perimeter portion


121


of the layer


120


that extends out beyond the support member


106


when assembled thereto. When the wound treatment device


100


is assembled, a circumferential edge


122


of the layer


120


is joined to a corresponding circumferential edge


132


of the lower collar


130


. Preferably, the edges


122


and


132


are sealed or welded together by a heat process. When so joined, the outer perimeter portion


121


of the layer


120


and the lower collar


130


form the membrane


110


, which extends over the outside of the outer perimeter


118


of the support member


106


. The lower collar has a ring-like shape that includes an inner periphery


131


. An inner periphery portion


133


comprises an annular portion of the lower collar material on a surface of the lower collar that faces away from the lower surface


109


of the support member


106


. The lower surface


109


is not shown in

FIG. 17

, but may be seen in

FIGS. 19A and 19B

.




The membrane


110


of the transition portion


108


is attached to the attachment portion


102


by heat-bonding or otherwise connecting the inner periphery portion


133


of the lower collar


130


at or near the opposing inner periphery portion


111




i


of the attachment portion


102


.




Many variations of the assembly illustrated in

FIGS. 15 and 17

are possible. For example, the support member


106


could be contained within the structure formed by the layer


120


, lower collar


130


, and attachment portion


102


, unattached to any portion of the structure.





FIG. 16

shows a detachable heater


140


positioned on the wound cover


105


within a pocket formed between the layer


120


and the stretcher layer


125


, with the opening to the pocket provided by one of the slits


128


. The wound cover


105


, with the heater


140


contained within the pocket, is supported substantially in a plane or surface above a wound by the support member


106


. The heater


140


is generally planar and may be connected to and powered by a portable power supply such as that illustrated in FIG.


7


.




Refer now to

FIGS. 18-18C

in which

FIGS. 18A and 18B

show details of the wound treatment device


100


when assembled and put in use.

FIG. 18A

illustrates the relationship of the attachment portion


102


with respect to the support member


106


of the wound treatment portion


104


. In this regard, when the wound treatment device is assembled and placed on a flat surface, the attachment portion


102


and wound treatment portion


104


substantially align along the inner perimeters


119


and


111




e.






The seal between the inner periphery portion


133


of the lower collar


130


and the inner periphery portion


111




i


of the attachment portion


102


lies beneath the lower surface of the support member


106


. This is the surface that is indicated by reference numeral


109


in

FIGS. 19A and 19B

. Preferably, the seal joining the inner periphery portions


133


and


111




i


is a continuous, closed-loop seal. Although, for reasons explained below, this is the preferred location of the seal between the lower collar


130


and attachment portion


102


, the inventors contemplate that the seal could comprise a substantially continuous, closed-loop trace anywhere between the outer perimeter


111




o


and inner perimeter


111




e


of the attachment member


102


.




In

FIGS. 17 and 18A

, the seal between the edges


122


and


132


of the layer


120


and lower collar


130


is exaggerated as a flange. In practice, the shape of the membrane


110


extending from an upper outer edge


107




ue


of the upper surface


107


to a lower outer edge


118




be


of the outer perimeter


118


is rather elongated, with the flange much less pronounced than shown in FIG.


18


A. Of course, the membrane


110


in the extent from the edge


107




ue


all the way down to the seal that joins the inner periphery portions


133


and


111




i


is not attached, and is therefore free from, although in close proximity to, the outer perimeter


118


, lower edge


118




be


and lower surface


109


of the support member


106


.




Referring now to

FIGS. 18B-19B

, the flexible, non-contact wound treatment device


100


is suitable for placement onto a skin surface


150


of a patient or person so as to include a selected wound area


152


that abuts a treatment volume


156


within the treatment device


100


. This attachment may be directly to the skin surface


150


, or on another member such as an ostomy ring that is, in turn, mounted or attached to the skin surface


150


. As

FIGS. 18B-19B

demonstrate, the flexible, non-contact wound treatment device


100


of this invention satisfies the objective previously stated by a capability of being conformably attached to an uneven, changing surface supporting a wound treatment portion


104


that remains reasonably or substantially planar in its shape, regardless of body contour or movements. In this regard, as

FIGS. 18B and 19B

illustrate, the attachment portion


102


operates as a hinge or flexion joint that pivots at the seal between the inner periphery portions


133


and


111




i


. Relatedly, the attachment portion


102


is free to conform to the shape of the skin surface by flexibly deforming between the inner and outer perimeters


111




e


and


111




o


. At the same time, the wound treatment portion


104


is relatively undeformed so that the support member


106


is able to support the layer


120


and stretcher layer


125


in a relatively planar orientation with respect to the wound area


152


. In the meantime, the wound treatment device


100


forms a barrier between the wound treatment v


6


lume


156


and the ambient atmosphere by virtue of the seal between the edges


122


and


132


of the layer


120


and lower collar


130


, and the seal between the inner periphery portions


133


and


111




i


. The bottom of the wound treatment device


100


is sealed to the skin


150


when the release layer


113


is peeled off so that the adhesive film layer


112


seals to the skin surface


150


.





FIGS. 18C and 19B

illustrate the conformability of the wound treatment device


100


provided by flexion of the membrane


110


in the transition portion


108


.

FIGS. 18C and 19B

are “snap shots” of the flexible, non-contact wound treatment device


100


after placement as described above with reference to

FIGS. 18B and 19A

and after movement of a body part on which the device


100


is placed. In these figures, movement is accommodated by excess length in the membrane


110


. In

FIGS. 18C and 19B

, the membrane


110


has tensioned along the perimeter


118


to provide strain relief between the lower edge


118




be


of the support member


106


and the seal between the inner periphery portions


133


and


111




i


. In addition, the flexibility of the membrane


110


and its freedom from the outer perimeter


118


and lower surface


109


permit a play out of excess length of the membrane


110


that abuts the outer perimeter


118


of the support member


106


. This moves the membrane


110


into close touching engagement with the outer perimeter


118


, while lengthening the amount of membrane


110


available between the lower edge


118


be and the inner periphery portion


111




i.






In another aspect, as

FIGS. 18C and 19B

show, the membrane


110


acts as a double hinge or a double pleat between the lower edge


118




be


of the support member


106


and the attachment portion


102


. A first hinge pivot or pleat is at the seal between


133


and


111




i


. This hinge permits the attachment portion to pivot toward and away from the wound treatment portion. The second hinge—at edge


118




be


—allows the wound treatment portion to move toward and away from the attachment portion. Manifestly, the same effect could be achieved by attachment of the membrane


110


to the lower surface


109


inside of the edge


118




be.






Three significant advantages result from placement of the attachment portion


102


beneath the support member


106


of the wound treatment portion.




First, in plan, the shapes and extents of the bottom surface


109


and the attachment portion


102


align and largely overlap, thereby reducing the “foot print” of the wound treatment device


100


to a single, substantially annular shape from the two concentric shapes of

FIGS. 2 and 3

.




Next, the double hinge (or pleat) provided by the membrane


110


increases the conformability of the wound treatment device to shape and movement, while maintaining the planarity of the wound cover and preventing its contact with a wound.




Last, the lower collar


130


, in extending substantially to the inner perimeter


111




e


of the attachment portion


102


forms a barrier to moisture and wound exudate which may be absorbed by the support member


106


, thereby reducing maceration of skin underneath the attachment portion


102


.




The Invention




Our flexible, non-contact wound treatment device with a single joint is illustrated, in perspective, in

FIG. 20. A

first preferred embodiment of our invention is illustrated in

FIGS. 21-23

, a second embodiment is illustrated in

FIGS. 24-26A

, B and C and a third embodiment is illustrated in

FIGS. 27-29

. Among these embodiments, identical reference numerals specify identical parts throughout the drawings.





FIG. 20

is a perspective view of the flexible, non-contact wound treatment device


200


for application to a patient's skin surface. An attachment portion


202


is formed as a collar or a flange. This attachment portion


202


is for attachment to a patient's skin around a wound by way of an adhesive layer on the underside of the attachment portion. Our preferred embodiment of the wound treatment device


200


also embraces a wound treatment portion


204


that includes a wound cover


205


, described below, supported by a support member in the form of a standoff


206


. A transition portion


208


with a single joint, described below with reference to two preferred embodiments, connects the wound treatment portion


204


to the attachment portion


202


.




In a first embodiment, illustrated in

FIGS. 21 and 22

, the transition portion


208


comprises a joint embodied as a pleated member


210


. The pleated member


210


comprises multiple stacked pleats so that it assumes an accordion- or bellows-like configuration that operates between a lower surface of the standoff


206


and an upper surface


219


of the attachment portion


202


.




In a second embodiment illustrated in

FIGS. 24

,


25


and


26


the transition portion


208


comprises a single joint in the form of a substantially continuous seam formed by glueing, heat-welding, or any other equivalent and appropriate attachment procedure between the upper surface


219


of the attachment portion


202


and the lower surface of the standoff


206


. Such a seam may be positioned, as preferred, on the surface


219


between inner and outer perimeters of the attachment portion


202


. Three exemplary traces showing the location of the seam with respect to the upper surface


219


are indicated by


208


/


220


, by


208


/


221


, and by


208


/


222


.




In a third embodiment, illustrated in

FIGS. 27-29

, the transition portion


208


comprises a “living hinge” in the form of a narrow bridge


209


of foam material in a preferably continuous annulus that spans and provides a hinge between attachment portion


202


and the lower surface of the standoff


206


. Such a bridge may be positioned, as preferred, between the attachment portion


202


and the standoff


206


within the inner and outer perimeters of the attachment portion


202


. Although only a single exemplary location of the bridge is shown, it is to be understood that many other locations would also be possible.




Referring now to

FIGS. 22 and 25

, in the wound treatment device


200


, the attachment portion


202


is an integrated, unitary assembly preferably having the three sections, the properties, and the operations described above with reference to

FIGS. 15 and 17

. In this regard, the attachment portion


202


is a flexible, collar-shaped part with an inner perimeter


222


and an outer perimeter


223


. The upper surface


219


of the attachment member


202


faces, and therefore is disposed under, or beneath, the support member


206


, facing its lower surface.




The wound treatment portion


204


includes a support member preferably in the form of the standoff


206


, which is preferably a ring of absorbent foam. Such foam may comprise, for example, naturally open-celled polyurethane foam that is selected to have favorable characteristics of absorbency, leaking and resevoiring. Preferably, the foam may be of the type known as “self-skinning foam.” Such material is available as products sold under the trade names Aquazone and P100Z, from Foamex. Typically, self-skinning foam forms a non-permeable skin when molded. Thus the upper surface


225


, the outer surface


226


, and the lower surface of the standoff


206


(not shown, but oppositely-directed from the upper surface


225


) are “skinned”, while the center of the standoff


206


is die cut to expose the open cell structure on the inner surface


227


. Thus, the inner surface


227


has the desirable property of absorbency (among others) described above with reference to the standoff of the wound treatment devices illustrated in

FIGS. 1-19

. The thickness of the standoff


206


is preferably in a range extending from


{fraction (1/2″+L )} to




{fraction (5/8″+L )}, with the exact dimension being selected to maintain non-contact at wound sites whereby, during use, the standoff 206 can compress and conform without the wound cover contacting the wound. Alternatively, if a high moisture-vapor transission rate (MVTR) is desirable, the outer surface 226 may also be die cut exposing the open cells of the foam to the environment. Further, the standoff 206 may be altogether skinless if required.






The wound cover


205


includes a layer


230


preferably of 4 mil.-thick clear, flexible polyurethane film with favorable characteristics selected, but not limited, to include moisture vapor transfer, oxygen permeability, and transmission of infrared radiation. Such material is available as a product sold under the name Deerfield 6100S. The layer


230


is attached to the upper surface


225


of the support member


206


by a ring of adhesive (not shown) comprising a synthetic rubber-based adhesive such as the product sold under the trade name HL-2306X by H. B. Fuller Adhesive. When the layer


230


is attached to the upper surface


225


of the support member


206


, its edge or perimeter is substantially flush with the edge or perimeter formed in the upper surface


225


by the outer surface


226


. The wound cover


205


further includes a stretcher layer


232


attached to the layer


230


so that the layer


230


is sandwiched between the stretcher layer


232


and the upper surface


225


of the standoff


206


. The stretcher layer


232


is preferably a 5 mil.-thick planar sheet of (preferably) clear, somewhat flexible polyester film having enough stiffness to aid in maintaining planarity of the wound treatment portion


204


. The function of the stretcher layer


232


is to hold the layer


230


taut, much as a “stretcher frame” tautens an artist's canvas. The stretcher layer


232


is attached to the layer


230


by a layer of adhesive (not shown) comprising a clear flexible polyester carrier film coated on both sides with an aggressive adhesive. The stretcher layer


232


further includes a pair of slits


233


that receive a detachable heater. With the provision of the slits


233


, a pocket is formed between the stretcher layer


232


and the layer


230


.




Many variations of the materials and shapes of the elements thus far described are within the contemplation of the inventors.




With reference again to

FIG. 20

, a detachable heater


240


may be positioned on, or in, the wound cover


205


within the pocket formed therein, with the opening to the pocket provided by either of the slits


233


. The wound cover


205


, with the heater


240


contained within the pocket, is supported substantially in a plane or surface above a wound by the support member


206


. The heater


240


is illustrated as being planar, but may comprise other shapes. Preferably, the heater


240


is connected to and powered by a portable power supply


241


. When the heater


240


is received within the pocket and powered by the power supply


241


, heat treatment of a wound by radiation through a treatment volume formed by the support member


206


and the wound cover


205


may be provided as described above.




Referring again to

FIGS. 22 and 25

, first and second embodiments of the transition portion


208


are illustrated. It is understood that these embodiments are only representative of the general principle of providing a joint between the attachment portion


202


and the wound treatment portion


204


that acts between the bottom surface of the standoff


206


and the top surface


219


of the attach nient portion


202


.

FIGS. 21

,


22


,


24


, and


25


are cross-sectional perspective views of the first and second embodiments taken along lines A—A of FIG.


20


.




With reference to

FIGS. 21 and 22

, the first embodiment of a flexible non-contact wound treatment device with a joint acting between the attachment and wound treatment portions includes a joint embodied by the pleated member


210


. The pleated member


210


is adhered, bonded, or otherwise attached along an upper edge


210




a


to the bottom surface of the standoff


206


. The pleated member


210


is attached along a lower edge


210




b


by adhesive, heat bonding, or other appropriate means to the top surface


219


of the flexible attach rnent member


202


. Preferably, as shown in

FIG. 21

, the pleated member


210


is attached to the lower surface of the standoff


206


near an inner perimeter


228


where the lower surface transitions to the inner surface


227


. Similarly, the pleated member


210


is preferably attached to the upper surface


219


of the attachment portion


202


near the inner perimeter


222


. This is shown clearly in

FIGS. 21 and 23

. Nevertheless, the pleated member


210


could be dimensioned to be attached between the attachment and wound treatment portions


202


and


204


along any closed-looped trace between the lower surface of the standoff


206


and the upper surface


219


of the attachment portion


204


. Preferably, the pleated member comprises a urethane film which may be molded or extruded to form the multiple stacked pleats shown in the figures.




Manifestly, construction details of the wound treatment device may result in the pleated member


210


being connected indirectly to either, or both, of the standoff and attachment portion. However, as long as the pleated member acts between these or equivalent elements in the location shown and for the purpose described, it will meet the definition of the invention.




As shown in

FIGS. 21

,


22


and


23


, the flexible, non-contact wound treatment device


200


with a transition portion


208


in the first embodiment in the form of a pleated member


210


is suitable for placement onto a skin surface


250


so as to surround a selected wound area


252


that abuts a treatment volume


256


enclosed or contained within the wound treatment device


200


. This attachment may be directly to the skin surface


250


, or on another member such as an ostomy ring that is, in turn, mounted or attached to the skin surface


250


. As

FIGS. 21 and 23

illustrate, the flexible, non-contact wound treatment device


200


of this invention satisfies the objective previously stated by a capability of being conformably attached to an uneven, changing surface supporting a wound treatment portion


204


that remains reasonably or substantially in its original shape, regardless of body contour or movements. In this regard, as

FIGS. 21

,


22


and


23


illustrate, the attachment portion


202


operates as a flexion joint that flexes to adapt to the contour of the skin surface


252


. In addition, the transition portion


208


in the form of the pleated member


210


supports relative movement between the attachment and wound treatment portions


202


and


204


, permitting them to move toward and away from each other, and also parallel to each other, thereby enhancing the conformability of the wound treatment device


200


to contour and movement of the body. Relatedly, the attachment portion


202


is free to conform to the shape of the skin surface


250


by flexibly deforming between the inner and outer perimeters


222


and


223


. At the same time, the wound treatment portion


204


is relatively undeformed so that the standoff


206


is able to support the layer


230


and stretcher


232


in a predetermined orientation with respect to the wound area


252


. In the meantime, the wound treatment device


200


forms a barrier between the wound treatment volume


256


and the ambient atmosphere by virtue of the seal between the wound cover


205


and the standoff


206


, the skinned outer and lower surfaces of the standoff


206


, and the seals between the pleated member


210


and the standoff


206


and attachment portion


202


. The bottom of the wound treatment device


200


is sealed to the skin


250


when the release layer (not shown) is peeled off so that the lower adhesive film layer (not shown) of the attachment portion


202


seals to the skin surface


250


.




The second embodiment of the transition portion


208


may be understood with reference to

FIGS. 24

,


25


and


26


A-


26


C. In this regard, the transition portion comprises a seam acting between the lower surface of the standoff


206


and the upper surface


219


of the attachment portion


202


. Three possible seam locations are shown in FIG.


25


. Such a seam may be formed by any appropriate means of attachment between the attachment portion


202


and the lower surface of the standoff


206


. Such may include, without limitation, adhesive attachment, heat bonding, or any other appropriate measure.




As with the first embodiment of the joint, the inventors contemplate that a seam may be placed between other elements that effectively connect the seam to the attachment portion


202


and the lower surface of the standoff


206


in the location shown and for the purposes described.




The second embodiment of the transition portion


208


effectively allows articulation between the attachment portion


202


and the wound treatment portion


204


. This is shown clearly in FIGS.


24


and


26


A-


26


C. For example, in

FIGS. 24 and 26B

, the seal is in the location indicated by


208


/


220


in

FIG. 25

, essentially sealing an outer periphery of the upper surface


219


near the outer perimeter


223


to a corresponding outer periphery of the lower surface of the standoff


206


. This permits the section of attachment portion


202


extending to the inner perimeter


222


to articulate toward or away from the lower surface of the stand off


206


.

FIG. 26A

shows attachment of the attachment portion


202


along the seam


208


/


222


to the lower surface of the standoff


206


near the inner perimeter


222


, where the section of the attachment portion


202


extending to the outer perimeter


223


can articulate toward or away from the lower surface of the standoff


206


.

FIG. 26C

shows attachment of the upper surface


219


to the lower surface of the standoff


206


along the seam


208


/


221


. In this location, the seam permits articulation of multiple sections of the attachment portion


202


.




The third embodiment of the transition portion


208


may be understood with reference to

FIGS. 2-29

. In these figures, the transition portion comprises a bridge of foam material spanning and providing a narrow passage through the space between the bottom surface of the standoff


206


and the top surface


219


of the attachment portion


202


. The bridge


209


is provided during the manufacture of the standoff


206


and the attachment portion


202


as an integrated, unitary piece by, for example, molding open-celled plastic foam of the self-skinning type. In this case, the bridge


209


is provided for in the mold and forms concurrently and integrally with the standoff


206


and the attachment portion


202


. After molding, an adhesive fil m layer with an attached release liner


112


,


113


(both described above with respect to the wound treatment device illustrated in

FIGS. 15-17

) may be attached to the lower surface of the attachment portion for application of the wound treatment device to a skin surface. Manifestly, the bridge


209


may be selectively located between the inner and outer perimeters


222


and


223


of the attachment portion


202


as with the first and second embodiments described above. In all other respects, the wound treatment device of

FIGS. 27-29

is substantially identical with the wound treatment devices in

FIGS. 20-26C

.




As with the second embodiment, the bridge


209


effectively allows articulation between the attachment portion


202


and the wound treatment portion


204


.




Three significant advantages result from placement of a joint beneath the standoff


206


of the wound treatment portion


204


.




First, in plan, the shapes and extents of the bottom surface of the standoff


206


and the attachment portion


202


align and largely overlap, thereby reducing the “footprint” of the wound treatment device


200


to a single, substantially annular shape (which may be many-sided or circular), from the concentric shapes of

FIGS. 2 and 3

.




Next, the joint acting between the lower surface of the standoff


206


and the upper surface


219


of the attachment portion


202


increases conformability of the wound treatment device


200


to shape and movement, while maintaining the predetermined shape of the wound cover


205


and preventing its contact with the wound.




Last, the joint acting between the lower surface of the standoff


206


and the upper surface


219


of the attachment portion


202


forms a barrier to moisture and wound exudate which may be absorbed by the inner surface


227


of the standoff


206


, thereby reducing maceration of the skin underneath the attachment portion


202


.




While the invention has been illustrated by means of specific embodiments and examples of use, it will be evident to those skilled in the art that many variations and modifications may be made therein without deviating from the scope and spirit of the invention. However, it is to be understood that the scope of the present invention is to be limited only by the appended claims.



Claims
  • 1. A non-contact wound treatment device, comprising:a flexible attachment portion having an opening defined by a closed perimeter; a support member having an opening; the attachment portion and support member openings aligned to form a wound treatment volume; and a joint connecting the support member and attachment portion; and the joint positioned between a surface of the support member and a surface of the attachment portion that overlaps and faces the surface of the support member, the joint permitting relative movement between the support member and the attachment portion.
  • 2. The non-contact wound treatment device of claim 1, wherein the joint comprises a pleated member attached to the surface of the support member and to the surface of the attachment portion.
  • 3. The non-contact wound treatment device of claim 1, wherein the joint comprises a seam between the surface of the support member and the surface of the attachment portion.
  • 4. The non-contact wound treatment device of claim 1, wherein the joint comprises a bridge of material between the surface of the support member and the surface of the attachment portion.
  • 5. The non-contact wound treatment device of claim 1, wherein the support member and the attachment portion are annular.
  • 6. The non-contact wound treatment device of claim 1, further including a wound cover on the support member, over the opening in the support member.
  • 7. The non-contact wound treatment device of claim 6, further including a heater.
  • 8. The non-contact wound treatment device of claim 7, wherein the wound cover and heater are substantially planar.
  • 9. The non-contact wound treatment device of claim 8, wherein the joint comprises a pleated member.
  • 10. The non-contact wound treatment device of claim 8, wherein the joint comprises a seam.
  • 11. The non-contact wound treatment device of claim 8, wherein the joint comprises a bridge of material.
  • 12. The non-contact wound treatment device of claim 1, wherein the surface of the support member is a lower surface and the surface of the attachment member is an upper surface.
CROSS REFERENCE TO RELATED CASES

This application is a continutation of Ser. No. 08/843,072 filed Apr. 11, 1997, which is a Continuation-in-Part of U.S. patent application Ser. No. 08/342,741, filed Nov. 21, 1994 now U.S. Pat. No. 5,817,145 titled WOUND TREATMENT DEVICE, assigned commonly with this application.

US Referenced Citations (65)
Number Name Date Kind
222690 Goldschmidt Dec 1879
697637 Lee Apr 1902
720812 Johnson Feb 1903
1384467 Homan Jul 1921
1399095 Webb, Sr. Dec 1921
1777982 Popp Oct 1930
1920808 Sander Aug 1933
1979082 Schwedenberg et al. Oct 1934
2221758 Elmquist Nov 1940
2443481 Sene Jun 1948
2573791 Howells Nov 1951
2577945 Atherton Dec 1951
2599523 Dorr Jun 1952
2601189 Wales, Jr. Jun 1952
2632443 Lesher Mar 1953
2706988 Weber Apr 1955
2769892 Collins Nov 1956
3026874 Stevens Mar 1962
3528416 Chamberlain Sep 1970
3596657 Eidus Aug 1971
3610238 Rich, Jr. Oct 1971
3610251 Sanderson Oct 1971
3687143 Schneeberger et al. Aug 1972
3691646 Ruffolo Sep 1972
3782377 Rychlik Jan 1974
3814095 Lubens Jun 1974
3867939 Moore Feb 1975
3881477 Von Otto May 1975
4080971 Leeper Mar 1978
4134399 Halderson Jan 1979
4172495 Zebuhr et al. Oct 1979
4279255 Hoffman Jul 1981
4341209 Schaar Jul 1982
4382441 Svedman May 1983
4399816 Spangler Aug 1983
4468227 Jensen Aug 1984
4484574 DeRusha et al. Nov 1984
4517972 Finch, Jr. May 1985
4540412 Van Overloop Sep 1985
4572188 Augustine et al. Feb 1986
4628930 Williams Dec 1986
4633863 Filips et al. Jan 1987
4641641 Strock Feb 1987
4641643 Greer Feb 1987
4667666 Fryslie May 1987
4890608 Steer Jan 1990
4962761 Golden Oct 1990
4969881 Viesturs Nov 1990
5003971 Buckley Apr 1991
5025777 Hardwick Jun 1991
5060662 Farnsworth, III Oct 1991
5086763 Hathman Feb 1992
5107832 Guibert et al. Apr 1992
5135518 Vera Aug 1992
5144113 Hall et al. Sep 1992
5144958 Krueger et al. Sep 1992
5170781 Loomis Dec 1992
5190031 Guibert et al. Mar 1993
5230350 Fentress Jul 1993
5431622 Pyrozyk et al. Jul 1995
5531670 Westby et al. Jul 1996
5580346 Spier Dec 1996
5609619 Pompei Mar 1997
5649972 Hochstein Jul 1997
6110197 Augustine et al. Aug 2000
Foreign Referenced Citations (22)
Number Date Country
269 938 Jul 1950 CH
378 465 Jul 1964 CH
31 02 674 Sep 1982 DE
31 18 232 Nov 1982 DE
35 39 533 May 1987 DE
8305 103 U Apr 1988 DE
0 355 186 Feb 1990 EP
0 424 165 Apr 1991 EP
0 485 657 May 1992 EP
0 607 472 Jul 1994 EP
1 303 238 Jul 1962 FR
1 489 127 Jul 1967 FR
1 527 887 Apr 1968 FR
2 544 202 Oct 1984 FR
3090 Jun 1902 GB
288 220 Jul 1927 GB
2 082 919 Mar 1982 GB
2 199 501 Jul 1988 GB
2 261 822 Jun 1993 GB
WO 89 04158 May 1989 WO
WO 94 00090 Jan 1994 WO
WO 96 15745 May 1996 WO
Non-Patent Literature Citations (2)
Entry
PCT/US 98/00344—Int. Filing date Jan. 14, 1998.
Carolyn Robinson et al, “Warm-Up Active Wound Therapy: A novel approach to the management of chronic venous stasis ulcers”, Journal of Vascular Nursing, Jun. 1998, pp. 38-42.
Continuations (1)
Number Date Country
Parent 08/843072 Apr 1997 US
Child 09/514499 US
Continuation in Parts (1)
Number Date Country
Parent 08/342741 Nov 1994 US
Child 08/843072 US